Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9157772 | Atherosclerosis | 2005 | 9 Pages |
Abstract
The present study suggests that the triglyceride transport vector, VLDL, can modulate PON1 metabolism and activity. This is due, in part, to an influence of the lipoprotein on PON1 secretion. PON1 was associated with VLDL in human serum, where triglycerides correlated independently with variations in serum mass and activity of the enzyme. VLDL-associated PON1 exerted an anti-oxidative effect, which may be of physiological benefit.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sara Deakin, Xenia Moren, Richard W. James,